First American Trust FSB Has $6.71 Million Position in CVS Health Co. (NYSE:CVS)

First American Trust FSB increased its position in CVS Health Co. (NYSE:CVS) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 84,971 shares of the pharmacy operator’s stock after buying an additional 1,895 shares during the period. First American Trust FSB’s holdings in CVS Health were worth $6,709,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Grant GrossMendelsohn LLC boosted its position in CVS Health by 21.5% during the fourth quarter. Grant GrossMendelsohn LLC now owns 11,112 shares of the pharmacy operator’s stock worth $811,000 after purchasing an additional 1,970 shares during the period. Crescent Grove Advisors LLC boosted its position in CVS Health by 30.2% during the fourth quarter. Crescent Grove Advisors LLC now owns 4,893 shares of the pharmacy operator’s stock worth $386,000 after purchasing an additional 1,136 shares during the period. LifePlan Financial LLC bought a new stake in CVS Health during the fourth quarter worth approximately $1,581,000. Donaldson Capital Management LLC boosted its position in shares of CVS Health by 9.2% in the fourth quarter. Donaldson Capital Management LLC now owns 9,677 shares of the pharmacy operator’s stock valued at $764,000 after acquiring an additional 812 shares during the period. Finally, Flputnam Investment Management Co. boosted its position in shares of CVS Health by 3.1% in the fourth quarter. Flputnam Investment Management Co. now owns 203,888 shares of the pharmacy operator’s stock valued at $16,099,000 after acquiring an additional 6,039 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 0.5 %

CVS Health stock traded up $0.32 during mid-day trading on Monday, hitting $68.96. The stock had a trading volume of 7,231,266 shares, compared to its average volume of 10,963,071. The stock has a 50-day simple moving average of $75.85 and a two-hundred day simple moving average of $73.78. The stock has a market capitalization of $86.92 billion, a PE ratio of 10.67, a P/E/G ratio of 0.91 and a beta of 0.52. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same quarter last year, the business earned $1.99 earnings per share. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. As a group, sell-side analysts forecast that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.86%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is currently 41.18%.

Insiders Place Their Bets

In other news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.24% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on CVS shares. Barclays started coverage on CVS Health in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 target price for the company. HSBC started coverage on CVS Health in a research note on Friday, December 22nd. They issued a “buy” rating and a $94.00 target price for the company. Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research note on Wednesday, April 10th. Leerink Partnrs reiterated an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Finally, Piper Sandler increased their price objective on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $89.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.